73.42
-4.82(-6.16%)
Currency In USD
| Previous Close | 78.24 |
| Open | 78.23 |
| Day High | 78.45 |
| Day Low | 71.99 |
| 52-Week High | 78.54 |
| 52-Week Low | 28.1 |
| Volume | 2.99M |
| Average Volume | 2.23M |
| Market Cap | 13.99B |
| PE | -18.59 |
| EPS | -3.95 |
| Moving Average 50 Days | 69.11 |
| Moving Average 200 Days | 49.87 |
| Change | -4.82 |
If you invested $1000 in BridgeBio Pharma, Inc. (BBIO) since IPO date, it would be worth $2,664.97 as of January 06, 2026 at a share price of $73.42. Whereas If you bought $1000 worth of BridgeBio Pharma, Inc. (BBIO) shares 5 years ago, it would be worth $1,143.08 as of January 06, 2026 at a share price of $73.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
PALO ALTO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that co-founder and CEO, Neil Kumar, Ph.
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
GlobeNewswire Inc.
Jan 02, 2026 12:30 PM GMT
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webina
BridgeBio to Participate in December Investor Conferences
GlobeNewswire Inc.
Nov 25, 2025 12:30 PM GMT
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will